Wednesday, November 15, 2017 from 8:30 AM to 4:00 PM EST
Add to Calendar 


The Ritz-Carlton 
1150 22nd St NW
Washington, DC 20037

Driving Directions 


Heather Chaney 
Friends of Cancer Research 


Wednesday, November 15
8:30 am - 4 pm
The Ritz Carlton
1150 22nd St NW, Washington, DC 20037


Friends of Cancer Research is proud to announce our 2017 Annual Meeting to address critical issues in the development of new oncology drugs. This year's meeting brings together leaders in cancer drug development from federal health and regulatory agencies, academic research, the private sector, and patient advocates for focused discussions on key issues surrounding the development and regulation of cancer drugs and therapies. The meeting will explore methods to expedite drug combination development and approvals.

Final Meeting Agenda

8:30am - Welcome
  • Ellen Sigal, Chair & Founder, Friends of Cancer Research
  • Jeff Allen, President & CEO, Friends of Cancer Research
8:35am - Breakfast Keynote
  • Scott Gottlieb, Commissioner, U.S. FDA
9:00am - Panel 1
Capitalizing on the Totality of Evidence to Streamline Approvals for Supplemental Indications
  • Moderator: George Demetri, Dana-Farber Cancer Institute, Harvard Medical School
  • Shanthi Ganeshan, Novartis Pharmaceuticals
  • Marian Johnson-Thompson, Komen Patient Advocate
  • Amy McKee, U.S. FDA
  • Pratik Multani, Ignyta
  • Jordan Schecter, Janssen
11:00am - Panel 2
Data Generation to Support Cross-labeling of Indications for Combination Products
  • Moderator: Kenneth Anderson, Dana-Farber Cancer Institute, Harvard Medical School
  • Roger Dansey, Merck
  • Ann Farrell, U.S. FDA
  • James Myers, U.S. FDA
  • Jim Omel, Cancer Research Advocate
  • Marc Scheineson, Alston & Bird LLP 

12:45pm - Lunch

1:45pm - Lunch Conversation

  • Richard Pazdur, U.S. FDA
  • Norman "Ned" Sharpless, NCI
  • Ellen Sigal, Friends of Cancer Research
2:15pm - Panel 3 
Updating Outdated Product Labels
  • Moderator: Jeff Allen, Friends of Cancer Research
  • Angela Green, Memorial Sloan Kettering Cancer Center
  • Linda House, Cancer Support Community
  • Rachel Sher, Association for Accessible Medicines
  • Josephine Torrente, Hyman, Phelps & McNamara, PC
  • Janet Woodcock, U.S. FDA
4:00pm - Closing Remarks
Jeff Allen, Friends of Cancer Research